The cancellation of the July USPSTF meeting raises new questions about future governance, membership, and recommendation development process for the influential clinical advisory body.
Avalere Health experts break down how states and payers can approach Medicaid work requirements amid shifting policy signals and legal uncertainty.
This episode spotlights the rising compliance pressures facing health plans, from tougher Fraud, Waste, and Abuse oversight to expanding Program Integrity requirements and new federal scrutiny across operations. In five minutes, Avalere Health experts break down the policies driving these shifts and what plans must watch now to stay compliant.
In the final installment of our Brain Health month series, Avalere Health experts examine what it takes to close the gaps between innovation and patient access.
In this Brain Health Month installment, Avalere Health experts draw lessons from a landmark Alzheimer's launch for manufacturers navigating approval and access.
Avalere Health experts discuss the recent court decision on Clover Health's Medicare Advantage Stars results lawsuit, and what health plans should be assessing for future potential impacts while appeals and next decisions play out.
In the second installment of our Brain Health Month series, Avalere Health experts discuss key insights from Dr. Roberta Diaz Brinton on menopause, brain health, and emerging opportunities to improve Alzheimer's disease outcomes in women.
Medicare risk adjustment is shifting. In five minutes, Avalere explains policy changes, RADV expansion, and how evolving models may affect payments and market strategy.
Avalere Health experts break down what a Delphi panel is, how it works, and why its structured methodology sets it apart from a traditional advisory board.
In the first installment of our Brain Health Month series, Avalere Health experts discuss precision medicine, diagnostics, and patient access in Alzheimer's disease.
CMS and HHS regulations are shaping AI use in health plans, driving transparency and accountability, and speeding responsible adoption across an increasingly automated system.
Introducing On the Record: Health Plan Perspectives—A rapid-fire series delivering expert clarity on major CMS and HHS rules. In five minutes, get the insights, implications, and decisive perspective leaders need now.
Prevention, technology-enabled whole-person care, real-time measurement, simplification, and accelerated innovation were key themes at the recent quality conference.
On March 17-18, the ICD-10 C&M Committee discussed proposals for 35+ new codes designed to improve accuracy, address emerging health issues, and strengthen disease reporting.
Changes in state and federal policies will drive patient access, financing, and provider reimbursement of cell and gene therapies.
Avalere Health Advisory experts unpack the recent state legislative activity around AI in healthcare, exploring recent trends, the impact of federal executive orders, and key considerations for industry stakeholders as they navigate these shifts.
European countries are advancing real-world data use in healthcare decision-making, but face challenges from differing national frameworks and regulations
Evolving digital health codes are reshaping how technology and care connect.
Distinct patient characteristics and cost profiles across rare epilepsies reinforce the value of disease-specific approaches in rare disease research.
Avalere Health experts discuss how they developed and deployed an analytic model to predict likely enrollment changes to assist clients in understanding the impacts on all lines of business as a result of upcoming federal policy changes.
